| Year |
Citation |
Score |
| 2022 |
Wider J, Undyala VVR, Lanske B, Datta NS, Przyklenk K. Parathyroid Hormone-Related Peptide and Its Analog, Abaloparatide, Attenuate Lethal Myocardial Ischemia-Reperfusion Injury. Journal of Clinical Medicine. 11. PMID 35566399 DOI: 10.3390/jcm11092273 |
0.408 |
|
| 2020 |
Kulek AR, Anzell A, Wider JM, Sanderson TH, Przyklenk K. Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury Cells. 9: 214. PMID 31952189 DOI: 10.3390/Cells9010214 |
0.456 |
|
| 2020 |
Kulek A, Raghunayakula S, Anzell A, Undyala V, Sanderson T, Przyklenk K. Myocardial Ischemia‐Reperfusion Injury: Does Disruption of Mitochondrial Cristae Integrity Play a Requisite Mechanistic Role? The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.02656 |
0.348 |
|
| 2019 |
Strubakos CD, Malik M, Wider JM, Lee I, Reynolds CA, Mitsias P, Przyklenk K, Hüttemann M, Sanderson TH. Non-invasive treatment with near-infrared light: A novel mechanisms-based strategy that evokes sustained reduction in brain injury after stroke. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19845149. PMID 31112450 DOI: 10.1177/0271678X19845149 |
0.383 |
|
| 2019 |
Sprick JD, Mallet RT, Przyklenk K, Rickards CA. Ischaemic and hypoxic conditioning: potential for protection of vital organs. Experimental Physiology. 104: 278-294. PMID 30597638 DOI: 10.1113/Ep087122 |
0.367 |
|
| 2019 |
Przyklenk K, Hutsell TC, Hata K, Whittaker P. Targeted Coronary Thrombolysis via "Pericardial" Administration of Lytic Agents? Journal of Thrombosis and Thrombolysis. 6: 83-88. PMID 10751788 DOI: 10.1023/A:1008870700908 |
0.329 |
|
| 2018 |
Smolensky Koganov E, Michelson AD, Yanachkov IB, Yanachkova MI, Wright GE, Przyklenk K, Frelinger AL. Publisher Correction: GLS-409, an Antagonist of Both P2Y and P2Y, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation. Scientific Reports. 8: 17580. PMID 30498241 DOI: 10.1038/S41598-018-35956-6 |
0.319 |
|
| 2018 |
Koganov ES, Michelson AD, Yanachkov IB, Yanachkova MI, Wright GE, Przyklenk K, Frelinger AL. GLS-409, an Antagonist of Both P2Y and P2Y, Potently Inhibits Canine Coronary Artery Thrombosis and Reversibly Inhibits Human Platelet Activation. Scientific Reports. 8: 14529. PMID 30266987 DOI: 10.1038/S41598-018-32797-1 |
0.357 |
|
| 2018 |
Sanderson TH, Wider JM, Lee I, Reynolds CA, Liu J, Lepore B, Tousignant R, Bukowski MJ, Johnston H, Fite A, Raghunayakula S, Kamholz J, Grossman LI, Przyklenk K, Hüttemann M. Publisher Correction: Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury. Scientific Reports. 8: 6729. PMID 29695825 DOI: 10.1038/S41598-018-25184-3 |
0.301 |
|
| 2018 |
Wider J, Undyala VVR, Whittaker P, Woods J, Chen X, Przyklenk K. Remote ischemic preconditioning fails to reduce infarct size in the Zucker fatty rat model of type-2 diabetes: role of defective humoral communication. Basic Research in Cardiology. 113: 16. PMID 29524006 DOI: 10.1007/S00395-018-0674-1 |
0.361 |
|
| 2018 |
Sanderson TH, Wider JM, Lee I, Reynolds CA, Liu J, Lepore B, Tousignant R, Bukowski MJ, Johnston H, Fite A, Raghunayakula S, Kamholz J, Grossman LI, Przyklenk K, Hüttemann M. Inhibitory modulation of cytochrome c oxidase activity with specific near-infrared light wavelengths attenuates brain ischemia/reperfusion injury. Scientific Reports. 8: 3481. PMID 29472564 DOI: 10.1038/S41598-018-21869-X |
0.344 |
|
| 2018 |
Lindsey ML, Bolli R, Canty JM, Du XJ, Frangogiannis NG, Frantz S, Gourdie RG, Holmes JW, Jones SP, Kloner RA, Lefer DJ, Liao R, Murphy E, Ping P, Przyklenk K, et al. Guidelines for experimental models of myocardial ischemia and infarction. American Journal of Physiology. Heart and Circulatory Physiology. 314: H812-H838. PMID 29351451 DOI: 10.1152/Ajpheart.00335.2017 |
0.51 |
|
| 2017 |
Przyklenk K, Whittaker P. Ischemic Conditioning Attenuates Platelet-Mediated Thrombosis: A Tale of Reverse Translation. Journal of Cardiovascular Pharmacology and Therapeutics. 22: 391-396. PMID 28793820 DOI: 10.1177/1074248417724871 |
0.381 |
|
| 2017 |
Przyklenk K, Whittaker P. The Future of Remote Ischemic Conditioning: New Perspectives After ERICCA and RIPHeart Journal of Cardiovascular Pharmacology and Therapeutics. 22: 295-296. PMID 28513214 DOI: 10.1177/1074248417710151 |
0.303 |
|
| 2017 |
Datta T, Przyklenk K, Datta NS. Parathyroid Hormone-Related Peptide: A Novel Endocrine Cardioprotective "Conditioning Mimetic". Journal of Cardiovascular Pharmacology and Therapeutics. 1074248417702976. PMID 28403647 DOI: 10.1177/1074248417702976 |
0.331 |
|
| 2016 |
Pearson C, Przyklenk K, Mika VH, Ayaz SI, Ellis M, Varade P, Tolomello R, Welch RD. Utility of point of care assessment of platelet reactivity (using the PFA-100®) to aid in diagnosis of stroke. The American Journal of Emergency Medicine. PMID 27955971 DOI: 10.1016/J.Ajem.2016.11.036 |
0.303 |
|
| 2016 |
Hausenloy DJ, Barrabes JA, Bøtker HE, Davidson SM, Di Lisa F, Downey J, Engstrom T, Ferdinandy P, Carbrera-Fuentes HA, Heusch G, Ibanez B, Iliodromitis EK, Inserte J, Jennings R, Kalia N, ... ... Przyklenk K, et al. Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery. Basic Research in Cardiology. 111: 70. PMID 27766474 DOI: 10.1007/S00395-016-0588-8 |
0.347 |
|
| 2016 |
Dong Y, Undyala VV, Przyklenk K. Inhibition of mitochondrial fission as a molecular target for cardioprotection: critical importance of the timing of treatment. Basic Research in Cardiology. 111: 59. PMID 27573530 DOI: 10.1007/S00395-016-0578-X |
0.352 |
|
| 2016 |
Kumar R, Bukowski MJ, Wider JM, Reynolds CA, Calo L, Lepore B, Tousignant R, Jones M, Przyklenk K, Sanderson TH. Mitochondrial dynamics following global cerebral ischemia. Molecular and Cellular Neurosciences. PMID 27567688 DOI: 10.1016/J.Mcn.2016.08.010 |
0.302 |
|
| 2016 |
Garratt KN, Whittaker P, Przyklenk K. Remote Ischemic Conditioning and the Long Road to Clinical Translation: Lessons Learned From ERICCA and RIPHeart. Circulation Research. 118: 1052-4. PMID 27034272 DOI: 10.1161/Circresaha.115.308102 |
0.423 |
|
| 2015 |
Heusch G, Bøtker HE, Przyklenk K, Redington A, Yellon D. Remote ischemic conditioning. Journal of the American College of Cardiology. 65: 177-95. PMID 25593060 DOI: 10.1016/J.Jacc.2014.10.031 |
0.481 |
|
| 2015 |
Przyklenk K. Ischaemic conditioning: pitfalls on the path to clinical translation. British Journal of Pharmacology. 172: 1961-73. PMID 25560903 DOI: 10.1111/Bph.13064 |
0.344 |
|
| 2014 |
Whittaker P, Przyklenk K. From ischemic conditioning to 'hyperconditioning': clinical phenomenon and basic science opportunity. Dose-Response : a Publication of International Hormesis Society. 12: 650-63. PMID 25552962 DOI: 10.2203/Dose-Response.14-035.Whittaker |
0.38 |
|
| 2014 |
Wider J, Przyklenk K. Ischemic conditioning: the challenge of protecting the diabetic heart. Cardiovascular Diagnosis and Therapy. 4: 383-96. PMID 25414825 DOI: 10.3978/J.Issn.2223-3652.2014.10.05 |
0.45 |
|
| 2014 |
Przyklenk K. microRNA-144: the 'what' and 'how' of remote ischemic conditioning? Basic Research in Cardiology. 109: 429. PMID 25080349 DOI: 10.1007/S00395-014-0429-6 |
0.45 |
|
| 2014 |
Przyklenk K, Sanderson TH, Hüttemann M. Clinical benefits of remote ischemic preconditioning: new insights...and new questions. Circulation Research. 114: 748-50. PMID 24577960 DOI: 10.1161/Circresaha.114.303331 |
0.421 |
|
| 2014 |
Przyklenk K. Role of extracellular vesicles in remote ischemic preconditioning: 'good things come in small packages'? Journal of Molecular and Cellular Cardiology. 69: 83-4. PMID 24512844 DOI: 10.1016/J.Yjmcc.2014.01.020 |
0.336 |
|
| 2014 |
Darling CE, Sala Mercado JA, Quiroga-Castro W, Tecco GF, Zelaya FR, Conci EC, Sala JP, Smith CS, Michelson AD, Whittaker P, Welch RD, Przyklenk K. Point-of-care assessment of platelet reactivity in the emergency department may facilitate rapid rule-out of acute coronary syndromes: a prospective cohort pilot feasibility study. Bmj Open. 4: e003883. PMID 24441051 DOI: 10.1136/Bmjopen-2013-003883 |
0.331 |
|
| 2013 |
Przyklenk K. 'Going out on a limb': SDF-1α/CXCR4 signaling as a mechanism of remote ischemic preconditioning? Basic Research in Cardiology. 108: 382. PMID 24002083 DOI: 10.1007/S00395-013-0382-9 |
0.478 |
|
| 2013 |
Przyklenk K. Reduction of myocardial infarct size with ischemic "conditioning": physiologic and technical considerations. Anesthesia and Analgesia. 117: 891-901. PMID 23960036 DOI: 10.1213/Ane.0B013E318294Fc63 |
0.456 |
|
| 2013 |
Ovize M, Thibault H, Przyklenk K. Myocardial conditioning: opportunities for clinical translation. Circulation Research. 113: 439-50. PMID 23908331 DOI: 10.1161/Circresaha.113.300764 |
0.467 |
|
| 2013 |
Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C in ischemic "conditioning": from first evidence to current perspectives. Journal of Cardiovascular Pharmacology and Therapeutics. 18: 525-32. PMID 23872508 DOI: 10.1177/1074248413494814 |
0.31 |
|
| 2013 |
Calo L, Dong Y, Kumar R, Przyklenk K, Sanderson TH. Mitochondrial dynamics: an emerging paradigm in ischemia-reperfusion injury. Current Pharmaceutical Design. 19: 6848-57. PMID 23590157 DOI: 10.2174/138161281939131127110701 |
0.366 |
|
| 2013 |
Sanderson TH, Reynolds CA, Kumar R, Przyklenk K, Hüttemann M. Molecular mechanisms of ischemia-reperfusion injury in brain: pivotal role of the mitochondrial membrane potential in reactive oxygen species generation. Molecular Neurobiology. 47: 9-23. PMID 23011809 DOI: 10.1007/S12035-012-8344-Z |
0.372 |
|
| 2013 |
Przyklenk K, Whittaker P. Genesis of remote conditioning: action at a distance--'hypotheses non fingo'? Journal of Cardiovascular Medicine (Hagerstown, Md.). 14: 180-6. PMID 22964648 DOI: 10.2459/Jcm.0B013E328358C8Eb |
0.404 |
|
| 2012 |
Przyklenk K, Dong Y, Undyala VV, Whittaker P. Autophagy as a therapeutic target for ischaemia /reperfusion injury? Concepts, controversies, and challenges. Cardiovascular Research. 94: 197-205. PMID 22215722 DOI: 10.1093/Cvr/Cvr358 |
0.363 |
|
| 2011 |
Whittaker P, Przyklenk K. Remote-conditioning ischemia provides a potential approach to mitigate contrast medium-induced reduction in kidney function: a retrospective observational cohort study. Cardiology. 119: 145-50. PMID 21952203 DOI: 10.1159/000330930 |
0.361 |
|
| 2011 |
Schwartz Longacre L, Kloner RA, Arai AE, Baines CP, Bolli R, Braunwald E, Downey J, Gibbons RJ, Gottlieb RA, Heusch G, Jennings RB, Lefer DJ, Mentzer RM, Murphy E, Ovize M, ... ... Przyklenk K, et al. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. Circulation. 124: 1172-9. PMID 21900096 DOI: 10.1161/Circulationaha.111.032698 |
0.507 |
|
| 2011 |
Przyklenk K, Whittaker P. Remote ischemic preconditioning: current knowledge, unresolved questions, and future priorities. Journal of Cardiovascular Pharmacology and Therapeutics. 16: 255-9. PMID 21821525 DOI: 10.1177/1074248411409040 |
0.49 |
|
| 2011 |
Przyklenk K. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum. Drugs & Aging. 28: 331-43. PMID 21542657 DOI: 10.2165/11587190-000000000-00000 |
0.421 |
|
| 2011 |
Przyklenk K, Whittaker P. Cardioprotection via adaptation to hypoxia: expanding the timeline and targets? Basic Research in Cardiology. 106: 325-8. PMID 21468767 DOI: 10.1007/S00395-011-0169-9 |
0.464 |
|
| 2011 |
Przyklenk K, Undyala VV, Wider J, Sala-Mercado JA, Gottlieb RA, Mentzer RM. Acute induction of autophagy as a novel strategy for cardioprotection: getting to the heart of the matter. Autophagy. 7: 432-3. PMID 21187719 DOI: 10.4161/Auto.7.4.14395 |
0.504 |
|
| 2011 |
Vinten-Johansen J, Granfeldt A, Mykytenko J, Undyala VV, Dong Y, Przyklenk K. The multidimensional physiological responses to postconditioning. Antioxidants & Redox Signaling. 14: 791-810. PMID 20618066 DOI: 10.1089/Ars.2010.3396 |
0.426 |
|
| 2011 |
Przyklenk K, Maynard M, Greiner DL, Whittaker P. Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxidants & Redox Signaling. 14: 781-90. PMID 20578962 DOI: 10.1089/Ars.2010.3343 |
0.353 |
|
| 2010 |
Sala-Mercado JA, Wider J, Undyala VV, Jahania S, Yoo W, Mentzer RM, Gottlieb RA, Przyklenk K. Profound cardioprotection with chloramphenicol succinate in the swine model of myocardial ischemia-reperfusion injury. Circulation. 122: S179-84. PMID 20837911 DOI: 10.1161/Circulationaha.109.928242 |
0.514 |
|
| 2010 |
Dong Y, Undyala VV, Gottlieb RA, Mentzer RM, Przyklenk K. Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury. Journal of Cardiovascular Pharmacology and Therapeutics. 15: 220-30. PMID 20595626 DOI: 10.1177/1074248410370327 |
0.429 |
|
| 2009 |
Whittaker P, Przyklenk K. Fibrin architecture in clots: a quantitative polarized light microscopy analysis. Blood Cells, Molecules & Diseases. 42: 51-6. PMID 19054699 DOI: 10.1016/J.Bcmd.2008.10.014 |
0.324 |
|
| 2009 |
Darling CE, Michelson AD, Volturo GA, Przyklenk K. Platelet reactivity and the identification of acute coronary syndromes in the emergency department. Journal of Thrombosis and Thrombolysis. 28: 31-7. PMID 18600429 DOI: 10.1007/S11239-008-0242-X |
0.372 |
|
| 2008 |
Przyklenk K, Maynard M, Darling CE, Whittaker P. Aging mouse hearts are refractory to infarct size reduction with post-conditioning. Journal of the American College of Cardiology. 51: 1393-8. PMID 18387442 DOI: 10.1016/J.Jacc.2007.11.070 |
0.351 |
|
| 2008 |
Whittaker P, Donovan JL, Przyklenk K. Reduction in emergency department visits by patients attending an anticoagulation clinic Journal of Thrombosis and Thrombolysis. 25: 132-132. DOI: 10.1007/S11239-007-0117-6 |
0.329 |
|
| 2007 |
Linden MD, Furman MI, Frelinger AL, Fox ML, Barnard MR, Li Y, Przyklenk K, Michelson AD. Indices of platelet activation and the stability of coronary artery disease. Journal of Thrombosis and Haemostasis : Jth. 5: 761-5. PMID 17371489 DOI: 10.1111/J.1538-7836.2007.02462.X |
0.343 |
|
| 2007 |
Przyklenk K, Whittaker P. Adaptation of a photochemical method to initiate recurrent platelet-mediated thrombosis in small animals. Lasers in Medical Science. 22: 42-5. PMID 17333457 DOI: 10.1007/S10103-006-0410-1 |
0.389 |
|
| 2007 |
Darling CE, Solari PB, Smith CS, Furman MI, Przyklenk K. 'Postconditioning' the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Research in Cardiology. 102: 274-8. PMID 17235447 DOI: 10.1007/S00395-007-0643-6 |
0.472 |
|
| 2006 |
Linden MD, Whittaker P, Frelinger AL, Barnard MR, Michelson AD, Przyklenk K. Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation. Journal of Thrombosis and Haemostasis : Jth. 4: 2670-7. PMID 16995902 DOI: 10.1111/J.1538-7836.2006.02228.X |
0.367 |
|
| 2006 |
Yuan C, Guo Y, Ravi R, Przyklenk K, Shilkofski N, Diez R, Cole RN, Murphy AM. Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts-- evidence for novel phosphorylation sites. Proteomics. 6: 4176-86. PMID 16791825 DOI: 10.1002/Pmic.200500894 |
0.356 |
|
| 2006 |
Przyklenk K, Maynard M, Whittaker P. First molecular evidence that inositol trisphosphate signaling contributes to infarct size reduction with preconditioning. American Journal of Physiology. Heart and Circulatory Physiology. 291: H2008-12. PMID 16731645 DOI: 10.1152/Ajpheart.00313.2006 |
0.413 |
|
| 2006 |
Przyklenk K, Maynard M, Whittaker P. Reduction of infarct size with D-myo-inositol trisphosphate: role of PI3-kinase and mitochondrial K(ATP) channels. American Journal of Physiology. Heart and Circulatory Physiology. 290: H830-6. PMID 16183728 DOI: 10.1152/Ajpheart.00799.2005 |
0.345 |
|
| 2005 |
Przyklenk K, Whittaker P. In vitro platelet responsiveness to adenosine-mediated "preconditioning" is age-dependent. Journal of Thrombosis and Thrombolysis. 19: 5-10. PMID 15976961 DOI: 10.1007/S11239-005-0849-0 |
0.394 |
|
| 2005 |
Darling CE, Jiang R, Maynard M, Whittaker P, Vinten-Johansen J, Przyklenk K. Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: role of ERK1/2. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1618-26. PMID 15937101 DOI: 10.1152/Ajpheart.00055.2005 |
0.51 |
|
| 2005 |
Przyklenk K, Maynard M, Darling CE, Whittaker P. Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. The Journal of Pharmacology and Experimental Therapeutics. 314: 1386-92. PMID 15919762 DOI: 10.1124/Jpet.105.087742 |
0.359 |
|
| 2005 |
Przyklenk K, Whittaker P. Cardioprotection with adenosine: 'a riddle wrapped in a mystery'. British Journal of Pharmacology. 145: 699-700. PMID 15895103 DOI: 10.1038/Sj.Bjp.0706261 |
0.461 |
|
| 2004 |
Colantonio DA, Van Eyk JE, Przyklenk K. Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovascular Research. 63: 217-25. PMID 15249179 DOI: 10.1016/J.Cardiores.2004.04.006 |
0.492 |
|
| 2004 |
Dickson EW, Whittaker P, Darling CE, Hirsch DJ, Blehar DJ, Przyklenk K. Brief apnea induces myocardial ischemic tolerance by an opioid-insensitive mechanism. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 13: 225-9. PMID 15210139 DOI: 10.1016/S1054-8807(04)00010-9 |
0.433 |
|
| 2004 |
Frelinger AL, Linden MD, Furman MI, Fox ML, Barnard MR, Li Y, Barringhaus K, Przyklenk K, Michelson AD. Patients with Coronary Artery Disease Have an Increased Incidence of Aspirin Resistance: Association of PFA-100 Closure Time with Clinical Findings. Blood. 104: 1859-1859. DOI: 10.1182/Blood.V104.11.1859.1859 |
0.329 |
|
| 2003 |
Przyklenk K, Li G, Simkhovich BZ, Kloner RA. Mechanisms of myocardial ischemic preconditioning are age related: PKC-epsilon does not play a requisite role in old rabbits. Journal of Applied Physiology (Bethesda, Md. : 1985). 95: 2563-9. PMID 12909609 DOI: 10.1152/Japplphysiol.00404.2003 |
0.436 |
|
| 2003 |
Przyklenk K, Darling CE, Dickson EW, Whittaker P. Cardioprotection 'outside the box'--the evolving paradigm of remote preconditioning. Basic Research in Cardiology. 98: 149-57. PMID 12883832 DOI: 10.1007/S00395-003-0406-Y |
0.468 |
|
| 2003 |
Przyklenk K, Heusch G. Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection? Journal of the American College of Cardiology. 41: 1195-7. PMID 12679221 DOI: 10.1016/S0735-1097(03)00087-1 |
0.477 |
|
| 2002 |
Kloner RA, Speakman MT, Przyklenk K. Ischemic preconditioning: a plea for rationally targeted clinical trials. Cardiovascular Research. 55: 526-33. PMID 12160949 DOI: 10.1016/S0008-6363(02)00237-7 |
0.4 |
|
| 2002 |
Dickson EW, Tubbs RJ, Porcaro WA, Lee WJ, Blehar DJ, Carraway RE, Darling CE, Przyklenk K. Myocardial preconditioning factors evoke mesenteric ischemic tolerance via opioid receptors and K(ATP) channels. American Journal of Physiology. Heart and Circulatory Physiology. 283: H22-8. PMID 12063270 DOI: 10.1152/Ajpheart.01055.2001 |
0.356 |
|
| 2002 |
Tubbs RJ, Porcaro WA, Lee WJ, Blehar DJ, Carraway RE, Przyklenk K, Dickson EW. Delta opiates increase ischemic tolerance in isolated rabbit jejunum. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 9: 555-60. PMID 12045067 DOI: 10.1197/Aemj.9.6.555 |
0.423 |
|
| 2002 |
Li G, Whittaker P, Yao M, Kloner RA, Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovascular Pathology : the Official Journal of the Society For Cardiovascular Pathology. 11: 158-65. PMID 12031768 DOI: 10.1016/S1054-8807(02)00102-3 |
0.356 |
|
| 2002 |
Kloner RA, Poole K, Shook T, Przyklenk K, Perritt K, Cannon CP. Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period. The American Journal of Cardiology. 89: 1291-3. PMID 12031730 DOI: 10.1016/S0002-9149(02)02328-7 |
0.402 |
|
| 2002 |
Kloner RA, Poole K, Shook T, Przyklenk K, Perritt K. Old age and myocardial infarct size in the reperfusion era Journal of the American College of Cardiology. 39: 302. DOI: 10.1016/S0735-1097(02)81357-2 |
0.443 |
|
| 2001 |
Przyklenk K, Li G, Whittaker P. No loss in the In vivo efficacy of ischemic preconditioning in middle-aged and old rabbits Journal of the American College of Cardiology. 38: 1741-1747. PMID 11704390 DOI: 10.1016/S0735-1097(01)01603-5 |
0.427 |
|
| 2001 |
Dickson EW, Blehar DJ, Carraway RE, Heard SO, Steinberg G, Przyklenk K. Naloxone blocks transferred preconditioning in isolated rabbit hearts. Journal of Molecular and Cellular Cardiology. 33: 1751-1756. PMID 11549353 DOI: 10.1006/Jmcc.2001.1436 |
0.399 |
|
| 2001 |
Przyklenk K. Pharmacologic treatment of the stunned myocardium: the concepts and the challenges. Coronary Artery Disease. 12: 363-369. PMID 11491201 DOI: 10.1097/00019501-200108000-00005 |
0.317 |
|
| 2001 |
Kloner RA, Shook T, Cannon CP, Przyklenk K. Ischemic preconditioning: implications for the geriatric heart. American Journal of Geriatric Cardiology. 10: 145-151. PMID 11360839 DOI: 10.1111/J.1076-7460.2001.00002.X |
0.477 |
|
| 2001 |
Gysembergh A, Kloner RA, Przyklenk K. Pretreatment with the gap junction uncoupler heptanol does not limit infarct size in rabbit heart. Cardiovascular Pathology. 10: 13-17. PMID 11343990 DOI: 10.1016/S1054-8807(00)00056-9 |
0.516 |
|
| 2001 |
Horn M, Weidensteiner C, Scheffer H, Meininger M, Groot Md, Remkes H, Dienesch C, Przyklenk K, Kienlin Mv, Neubauer S. Detection of myocardial viability based on measurement of sodium content: A (23)Na-NMR study. Magnetic Resonance in Medicine. 45: 756-764. PMID 11323801 DOI: 10.1002/Mrm.1103 |
0.4 |
|
| 2001 |
Gysembergh A, Simkhovich BZ, Kloner RA, Przyklenk K. p38 MAPK Activity is Not Increased Early During Sustained Coronary Artery Occlusion in Preconditioned Versus Control Rabbit Heart Journal of Molecular and Cellular Cardiology. 33: 681-690. PMID 11273721 DOI: 10.1006/Jmcc.2000.1331 |
0.438 |
|
| 2001 |
Przyklenk K, Kloner RA. Sildenafil citrate (Viagra) does not exacerbate myocardial ischemia in canine models of coronary artery stenosis. Journal of the American College of Cardiology. 37: 286-292. PMID 11153753 DOI: 10.1016/S0735-1097(00)01049-4 |
0.447 |
|
| 2000 |
Horn M, Weidensteiner C, Scheffer H, Przyklenk K, Kienlin Mv, Neubauer S. Use of 23Na MRS to discriminate viable from non viable tissue: experimental studies. Magnetic Resonance Materials in Physics Biology and Medicine. 11: 42-43. PMID 11186982 DOI: 10.1007/Bf02678490 |
0.338 |
|
| 2000 |
Przyklenk K, Whittaker P. Brief Antecedent Ischemia Enhances Recombinant Tissue Plasminogen Activator–Induced Coronary Thrombolysis by Adenosine-Mediated Mechanism Circulation. 102: 88-95. PMID 10880420 DOI: 10.1161/01.Cir.102.1.88 |
0.439 |
|
| 2000 |
Dickson EW, Porcaro WA, Fenton RA, Heard SO, Reindhardt CP, Renzi FP, Przyklenk K. ''Preconditioning at a Distance'' in the Isolated Rabbit Heart Academic Emergency Medicine. 7: 311-317. PMID 10805617 DOI: 10.1111/J.1553-2712.2000.Tb02228.X |
0.474 |
|
| 2000 |
Przyklenk K, Hata K, Whittaker P, Elliott GT. Monophosphoryl lipid A: a novel nitric oxide-mediated therapy to attenuate platelet thrombosis? Journal of Cardiovascular Pharmacology. 35: 366-75. PMID 10710120 DOI: 10.1097/00005344-200003000-00004 |
0.393 |
|
| 1999 |
Gysembergh A, Lemaire S, Piot C, Sportouch C, Richard S, Kloner RA, Przyklenk K. Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart American Journal of Physiology - Heart and Circulatory Physiology. 277. PMID 10600869 DOI: 10.1152/Ajpheart.1999.277.6.H2458 |
0.398 |
|
| 1999 |
Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP, Gysembergh A, Przyklenk K. Rabbit heart can be "preconditioned" via transfer of coronary effluent. The American Journal of Physiology. 277: H2451-7. PMID 10600868 DOI: 10.1152/Ajpheart.1999.277.6.H2451 |
0.487 |
|
| 1999 |
Hata K, Whittaker P, Kloner RA, Przyklenk K. Brief myocardial ischemia attenuates platelet thrombosis in remote, damaged, and stenotic carotid arteries. Circulation. 100: 843-8. PMID 10458721 DOI: 10.1161/01.Cir.100.8.843 |
0.411 |
|
| 1999 |
Przyklenk K, Simkhovich BZ, Bauer B, Hata K, Zhao L, Elliott GT, Kloner RA. Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium? Annals of the New York Academy of Sciences. 874: 192-210. PMID 10415532 DOI: 10.1111/J.1749-6632.1999.Tb09236.X |
0.46 |
|
| 1999 |
Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K. Preconditioning-induced cardioprotection and release of the second messenger inositol (1,4,5)-trisphosphate are both abolished by neomycin in rabbit heart. Basic Research in Cardiology. 94: 31-40. PMID 10097828 DOI: 10.1007/S003950050124 |
0.476 |
|
| 1998 |
Kloner RA, Przyklenk K, Shook T, Cannon CP. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. Journal of Thrombosis and Thrombolysis. 6: 89-92. PMID 10751789 DOI: 10.1023/A:1008833101817 |
0.367 |
|
| 1998 |
Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C as a cellular mediator of ischemic preconditioning: a critical review Cardiovascular Research. 40: 9-22. PMID 9876313 DOI: 10.1016/S0008-6363(98)00142-4 |
0.304 |
|
| 1998 |
Przyklenk K, Kloner RA. Ischemic Preconditioning: Exploring the Paradox Progress in Cardiovascular Diseases. 40: 517-547. PMID 9647608 DOI: 10.1016/S0033-0620(98)80002-9 |
0.495 |
|
| 1998 |
Simkhovich BZ, Kloner RA, Przyklenk K. Temporal changes in the subcellular distribution of protein kinase C in rabbit heart during global ischemia Basic Research in Cardiology. 93: 122-126. PMID 9601579 DOI: 10.1007/S003950050072 |
0.402 |
|
| 1998 |
Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, McCabe CH, Braunwald E. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation. 97: 1042-5. PMID 9531250 DOI: 10.1161/01.Cir.97.11.1042 |
0.354 |
|
| 1998 |
Hata K, Whittaker P, Kloner RA, Przyklenk K. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation. 97: 692-702. PMID 9495306 DOI: 10.1161/01.Cir.97.7.692 |
0.488 |
|
| 1997 |
Przyklenk K. Lethal Myocardial "Reperfusion Injury": The Opinions of Good Men. Journal of Thrombosis and Thrombolysis. 4: 5-6. PMID 10639217 DOI: 10.1023/A:1017549827004 |
0.402 |
|
| 1997 |
Przyklenk K, Hata K, Kloner RA. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation. 96: 1305-1312. PMID 9286963 DOI: 10.1161/01.Cir.96.4.1305 |
0.466 |
|
| 1997 |
Przyklenk K, Hata K, Zhao L, Kloner RA, Elliott GT. Disparate effects of preconditioning and MLA on 5'-NT and adenosine levels during coronary occlusion. The American Journal of Physiology. 273: H945-51. PMID 9277514 DOI: 10.1152/Ajpheart.1997.273.2.H945 |
0.487 |
|
| 1997 |
Kloner RA, Przyklenk K. Clinical evidence that nisoldipine attenuates stunning in patients post infarction. Cardiovascular Drugs and Therapy. 11: 17-18. PMID 9140671 DOI: 10.1023/A:1007731303011 |
0.392 |
|
| 1996 |
Birnbaum Y, Przyklenk K, Kloner RA. Time Frame of Ischemic Preconditioning: Is It Clinically Relevant? Journal of Cardiovascular Pharmacology and Therapeutics. 1: 339-346. PMID 10684435 DOI: 10.1177/107424849600100410 |
0.321 |
|
| 1996 |
Simkhovich BZ, Przyklenk K, Hale SL, Patterson M, Kloner RA. Direct evidence that ischemic preconditioning does not cause protein kinase C translocation in rabbit heart Cardiovascular Research. 32: 1064-1070. PMID 9015408 DOI: 10.1016/S0008-6363(96)00181-2 |
0.434 |
|
| 1996 |
Przyklenk K, Zhao L, Kloner RA, Elliott GT. Cardioprotection with ischemic preconditioning and MLA: role of adenosine-regulating enzymes? American Journal of Physiology-Heart and Circulatory Physiology. 271. PMID 8853335 DOI: 10.1152/Ajpheart.1996.271.3.H1004 |
0.43 |
|
| 1996 |
Whittaker P, Kloner RA, Przyklenk K. Intramyocardial Injections and Protection Against Myocardial Ischemia An Attempt to Examine the Cardioprotective Actions of Adenosine Circulation. 93: 2043-2051. PMID 8640981 DOI: 10.1161/01.Cir.93.11.2043 |
0.416 |
|
| 1996 |
Przyklenk K, Kloner RA. Role of protein kinase C in ischemic preconditioning: in search of the "pure and simple truth". Basic Research in Cardiology. 91: 41-43. DOI: 10.1007/Bf00788861 |
0.437 |
|
| 1996 |
Przyklenk K. Editorial: Oxygen radical scavengers as adjuvant therapy for coronary reperfusion Journal of Thrombosis and Thrombolysis. 3: 35-40. DOI: 10.1007/Bf00226408 |
0.473 |
|
| 1995 |
Simkhovich BZ, Whittaker P, Przyklenk K, Kloner RA. Transient pre-ischemic acidosis protects the isolated rabbit heart subjected to 30 minutes, but not 60 minutes, of global ischemia Basic Research in Cardiology. 90: 397-403. PMID 8585861 DOI: 10.1007/Bf00788501 |
0.444 |
|
| 1995 |
Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson CM, Poole WK, Cannon CP, McCabe CH, Braunwald E. Previous Angina Alters In-Hospital Outcome in TIMI 4 A Clinical Correlate to Preconditioning? Circulation. 91: 37-45. PMID 7805217 DOI: 10.1161/01.Cir.91.1.37 |
0.466 |
|
| 1995 |
Kloner RA, Przyklenk K, Whittaker P, Hale S. Preconditioning stimuli and inadvertent preconditioning Journal of Molecular and Cellular Cardiology. 27: 743-747. PMID 7776379 DOI: 10.1016/0022-2828(95)90079-9 |
0.453 |
|
| 1995 |
Przyklenk K, Ovize M, Bauer B, Kloner RA. Gender does not influence acute myocardial infarction in adult dogs American Heart Journal. 129: 1108-1113. PMID 7754940 DOI: 10.1016/0002-8703(95)90390-9 |
0.499 |
|
| 1995 |
Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model? Circulation. 92: 1546-57. PMID 7664439 DOI: 10.1161/01.Cir.92.6.1546 |
0.441 |
|
| 1995 |
Przyklenk K, Kloner RA. Low‐Dose IV Acetylcholine Acts As a “Preconditioning‐Mimetic” in the Canine Model Journal of Cardiac Surgery. 10: 389-395. PMID 7579832 DOI: 10.1111/J.1540-8191.1995.Tb00667.X |
0.484 |
|
| 1995 |
Kloner RA, Przyklenk K, Shook T, Matthews RV, Burstein S, Cannom DS, Isber N, Kay G. Clinical aspects of preconditioning and implications for the cardiac surgeon. Journal of Cardiac Surgery. 10: 369-375. PMID 7579829 DOI: 10.1111/J.1540-8191.1995.Tb00664.X |
0.475 |
|
| 1995 |
Kloner RA, Przyklenk K, Kay GL. Clinical Evidence for Stunned Myocardium after Coronary Artery Bypass Surgery Survey of Anesthesiology. 39: 4. DOI: 10.1097/00132586-199502000-00006 |
0.351 |
|
| 1995 |
Przyklenk K, Kloner RA. 706-3 The Protein Kinase C Inhibitor Polymyxin-B does not Block Preconditioning-induced Cardioprotection in the Canine Model Journal of the American College of Cardiology. 25: 43. DOI: 10.1016/0735-1097(95)91634-A |
0.428 |
|
| 1994 |
Ovize M, Kloner RA, Przyklenk K. Stretch preconditions canine myocardium. American Journal of Physiology-Heart and Circulatory Physiology. 266. PMID 8304494 DOI: 10.1152/Ajpheart.1994.266.1.H137 |
0.506 |
|
| 1994 |
Przyklenk K. Nicotine exacerbates postischemic contractile dysfunction of 'stunned' myocardium in the canine model. Possible role of free radicals. Circulation. 89: 1272-1281. PMID 8124816 DOI: 10.1161/01.Cir.89.3.1272 |
0.35 |
|
| 1994 |
Przyklenk K, Aoki A, Bellows S, Klinedinst D, Zubiate P, Hale SL, Simkhovich BZ, Kloner RA, Kay GL. Stunned myocardium following prolonged cardiopulmonary bypass: effect of warm versus cold cardioplegia in the canine model. Journal of Cardiac Surgery. 9: 506-516. PMID 8069045 DOI: 10.1111/Jocs.1994.9.3S.506 |
0.451 |
|
| 1994 |
Kloner RA, Przyklenk K, Kay GL. Clinical evidence for stunned myocardium after coronary artery bypass surgery. Journal of Cardiac Surgery. 9: 397-402. PMID 8069026 DOI: 10.1111/Jocs.1994.9.3S.397 |
0.434 |
|
| 1994 |
Whittaker P, Przyklenk K. Reduction of infarct size in vivo with ischemic preconditioning: Mathematical evidence for protection via non-ischemic tissue Basic Research in Cardiology. 89: 6-15. PMID 8010936 DOI: 10.1007/Bf00788673 |
0.398 |
|
| 1994 |
Przyklenk K, Simkhovich BZ, Bauer B, Kloner RA. Deterioration in myocardial blood flow following relief of sustained ischemia is not associated with release of endothelin into the coronary sinus. Basic Research in Cardiology. 89: 260-269. PMID 7945162 DOI: 10.1007/Bf00795618 |
0.463 |
|
| 1994 |
Przyklenk K, Kloner RA, Whittaker P. Synopsis of Ischemic Preconditioning: What have we Learned Since 1986? Developments in Cardiovascular Medicine. 148: 153-170. DOI: 10.1007/978-1-4615-2602-5_9 |
0.492 |
|
| 1994 |
Bauer B, Kloner RA, Przyklenk K. Preconditioning and the Coronary Vasculature Developments in Cardiovascular Medicine. 148: 61-72. DOI: 10.1007/978-1-4615-2602-5_4 |
0.531 |
|
| 1994 |
Ovize M, Kloner RA, Przyklenk K. Preconditioning and Myocardial Contractile Function Developments in Cardiovascular Medicine. 148: 41-60. DOI: 10.1007/978-1-4615-2602-5_3 |
0.54 |
|
| 1994 |
Kloner RA, Przyklenk K. Is Preconditioning Relevant to Clinical Medicine Developments in Cardiovascular Medicine. 148: 173-187. DOI: 10.1007/978-1-4615-2602-5_10 |
0.387 |
|
| 1993 |
Whittaker P, Kloner RA, Przyklenk K. Laser-mediated tansmural myocardial channels do not salvage acutely ischemic myocardium Journal of the American College of Cardiology. 22: 302-309. PMID 8509555 DOI: 10.1016/0735-1097(93)90848-U |
0.408 |
|
| 1993 |
Kloner RA, Przyklenk K. Understanding the jargon: a glossary of terms used (and misused) in the study of ischaemia and reperfusion Cardiovascular Research. 27: 162-166. PMID 8472266 DOI: 10.1093/Cvr/27.2.162 |
0.336 |
|
| 1993 |
Kloner RA, Przyklenk K. Cardioprotection with Angiotensin-Converting Enzyme Inhibitors: Redefined for the 1990s Clinical Cardiology. 16: 95-103. PMID 8435934 DOI: 10.1002/Clc.4960160204 |
0.415 |
|
| 1993 |
Przyklenk K, Kloner RA. Cardioprotection" by ACE-inhibitors in acute myocardial ischemia and infarction? Basic Research in Cardiology. 88: 139-154. PMID 8357329 DOI: 10.1007/978-3-642-72497-8_10 |
0.527 |
|
| 1993 |
Bauer B, Simkhovich BZ, Kloner RA, Przyklenk K. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury? Circulation. 88: 659-672. PMID 8339428 DOI: 10.1161/01.Cir.88.2.659 |
0.506 |
|
| 1993 |
Simkhovich BZ, Hale SL, Ovize M, Przyklenk K, Kloner RA. Ischemie preconditioning and long-chain acyl carnitine in the canine heart Coronary Artery Disease. 4: 387-392. PMID 8261212 DOI: 10.1097/00019501-199304000-00011 |
0.487 |
|
| 1993 |
Przyklenk K, Kloner RA. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis Cardiovascular Research. 27: 925-934. PMID 8221780 DOI: 10.1093/Cvr/27.6.925 |
0.466 |
|
| 1993 |
Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 87: 893-899. PMID 7680290 DOI: 10.1161/01.Cir.87.3.893 |
0.465 |
|
| 1992 |
Ovize M, Kloner RA, Hale SL, Przyklenk K. Coronary cyclic flow variations "precondition" ischemic myocardium. Circulation. 85: 779-789. PMID 1735170 DOI: 10.1161/01.Cir.85.2.779 |
0.544 |
|
| 1992 |
Ovize M, Przyklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation. 85: 2247-2254. PMID 1591839 DOI: 10.1161/01.Cir.85.6.2247 |
0.513 |
|
| 1992 |
Przyklenk K, Bauer B, Kloner RA. Reperfusion of hibernating myocardium: contractile function, high-energy phosphate content, and myocyte injury after 3 hours of sublethal ischemia and 3 hours of reperfusion in the canine model. American Heart Journal. 123: 575-588. PMID 1539508 DOI: 10.1016/0002-8703(92)90493-F |
0.477 |
|
| 1992 |
Przyklenk K, Kloner RA. Calcium antagonists and the stunned myocardium: a role during ischaemia? A role during reperfusion? Cardiovascular Research. 26: 82-84. PMID 1516115 DOI: 10.1093/Cvr/26.1.82 |
0.317 |
|
| 1992 |
Ovize M, Przyklenk K, Kloner RA. Partial coronary stenosis is sufficient and complete reperfusion is mandatory for preconditioning the canine heart. Circulation Research. 71: 1165-1173. PMID 1394878 DOI: 10.1161/01.Res.71.5.1165 |
0.478 |
|
| 1992 |
Ovize M, Li Y, Przyklenk K, Kloner RA. Evidence from experimental models for myocardial protection during ischemia Current Opinion in Cardiology. 7: 563-570. DOI: 10.1097/00001573-199208000-00005 |
0.459 |
|
| 1991 |
Kloner RA, Przyklenk K. Stunned and hibernating myocardium. Annual Review of Medicine. 42: 1-8. PMID 2035955 DOI: 10.1146/Annurev.Me.42.020191.000245 |
0.507 |
|
| 1991 |
Whittaker P, Boughner DR, Kloner RA, Przyklenk K. Stunned myocardium and myocardial collagen damage: differential effects of single and repeated occlusions. American Heart Journal. 121: 434-441. PMID 1990746 DOI: 10.1016/0002-8703(91)90709-Q |
0.384 |
|
| 1991 |
Kloner RA, Przyklenk K. Hibernation and Stunning of the Myocardium The New England Journal of Medicine. 325: 1877-1879. PMID 1961227 DOI: 10.1056/Nejm199112263252610 |
0.459 |
|
| 1991 |
Kloner R, Przyklenk K. Experimental infarct size reduction with calcium channel blockers. Journal of the American College of Cardiology. 18: 876-878. PMID 1869752 DOI: 10.1016/0735-1097(91)90815-Q |
0.495 |
|
| 1991 |
Przyklenk K, Kloner RA. Angiotensin converting enzyme inhibitors improve contractile function of stunned myocardium by different mechanisms of action. American Heart Journal. 121: 1319-1330. PMID 1850188 DOI: 10.1016/0002-8703(91)90134-4 |
0.392 |
|
| 1991 |
Reddy BR, Wynne J, Kloner RA, Przyklenk K. Pretreatment with the iron chelator desferrioxamine fails to provide sustained protection against myocardial ischaemia-reperfusion injury Cardiovascular Research. 25: 711-718. PMID 1799904 DOI: 10.1093/Cvr/25.9.711 |
0.497 |
|
| 1991 |
Przyklenk K, Kloner RA. Calcium Antagonists and Stunned Myocardium: Importance for Clinicians? Cardiovascular Drugs and Therapy. 5: 947-951. PMID 1756142 DOI: 10.1007/Bf00053557 |
0.393 |
|
| 1991 |
Przyklenk K, Kloner RA. Calcium antagonists and the stunned myocardium. Journal of Cardiovascular Pharmacology. 18. DOI: 10.1097/00005344-199106191-00017 |
0.446 |
|
| 1990 |
Przyklenk K, Whittaker P, Kloner RA. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic dysfunction. American Heart Journal. 119: 807-815. PMID 2321502 DOI: 10.1016/S0002-8703(05)80316-3 |
0.461 |
|
| 1990 |
Kloner RA, Przyklenk K. Progress in cardioprotection: The role of calcium antagonists American Journal of Cardiology. 66. PMID 2147358 DOI: 10.1016/0002-9149(90)90569-M |
0.489 |
|
| 1989 |
Przyklenk K, Ghafari GB, Eitzman DT, Kloner RA. Nifedipine administered after reperfusion ablates systolic contractile dysfunction of postischemic stunned myocardium Journal of the American College of Cardiology. 13: 1176-1183. PMID 2926068 DOI: 10.1016/0735-1097(89)90281-7 |
0.448 |
|
| 1989 |
Przyklenk K, Kloner RA. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow. Circulation Research. 64: 86-96. PMID 2909304 DOI: 10.1161/01.Res.64.1.86 |
0.48 |
|
| 1989 |
Przyklenk K, Kloner RA. What factors predict recovery of contractile function in the canine model of the stunned myocardium American Journal of Cardiology. 64. PMID 2782268 DOI: 10.1016/0002-9149(89)90741-8 |
0.477 |
|
| 1989 |
Reddy BR, Kloner RA, Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Radical Biology and Medicine. 7: 45-52. PMID 2753395 DOI: 10.1016/0891-5849(89)90099-3 |
0.45 |
|
| 1989 |
Przyklenk K. Effect of chronic ibuprofen therapy on early healing of experimentally induced acute myocardial infarction in dogs. American Journal of Cardiology. 63: 1146-1148. PMID 2705388 DOI: 10.1016/0002-9149(89)90099-4 |
0.489 |
|
| 1989 |
Przyklenk K, Kloner RA. Relationships between structure and effects of ACE inhibitors: comparative effects in myocardial ischaemic/reperfusion injury. British Journal of Clinical Pharmacology. 28. PMID 2690907 DOI: 10.1111/J.1365-2125.1989.Tb03592.X |
0.501 |
|
| 1989 |
Kloner RA, Przyklenk K, Patel B. Altered myocardial states. The stunned and hibernating myocardium. The American Journal of Medicine. 86: 14-22. PMID 2644829 DOI: 10.1016/0002-9343(89)90005-3 |
0.525 |
|
| 1989 |
Przyklenk K, Kloner RA. Is “stunned myocardium” a protective mechanism? Effect of acute recruitment and acute β-blockade on recovery of contractile function and high-energy phosphate stores at 1 day post-reperfusion American Heart Journal. 118: 480-489. PMID 2570519 DOI: 10.1016/0002-8703(89)90261-5 |
0.412 |
|
| 1989 |
Kloner RA, Przyklenk K, Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues. Circulation. 80: 1115-1127. PMID 2553296 DOI: 10.1161/01.Cir.80.5.1115 |
0.348 |
|
| 1988 |
Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial "stunning": a clinically relevant phenomenon. Annals of Internal Medicine. 108: 626-8. PMID 3279896 DOI: 10.7326/0003-4819-108-4-626 |
0.489 |
|
| 1988 |
Przyklenk K, Kloner RA. Effect of verapamil on postischemic “stunned” myocardium: Importance of the timing of treatment Journal of the American College of Cardiology. 11: 614-623. PMID 3278036 DOI: 10.1016/0735-1097(88)91540-9 |
0.461 |
|
| 1988 |
Przyklenk K. Oxygen-derived free radicals and 'stunned myocardium'. Free Radical Biology and Medicine. 4: 39-44. PMID 3277899 DOI: 10.1016/0891-5849(88)90009-3 |
0.443 |
|
| 1987 |
Przyklenk K, Patel B, Kloner RA. Diastolic Abnormalities of Postischemic "Stunned" Myocardium American Journal of Cardiology. 60: 1211-1213. PMID 3687764 DOI: 10.1016/0002-9149(87)90435-8 |
0.465 |
|
| 1987 |
Przyklenk K, Connelly CM, McLaughlin RJ, Kloner RA, Apstein CS. Effect of myocyte necrosis on strength, strain, and stiffness of isolated myocardial strips. American Heart Journal. 114: 1349-59. PMID 3687688 DOI: 10.1016/0002-8703(87)90536-9 |
0.41 |
|
| 1987 |
Przyklenk K, Kloner RA. Effect of oxygen-derived free radical scavengers on infarct size following six hours of permanent coronary artery occlusion: salvage or delay of myocyte necrosis? Basic Research in Cardiology. 82: 146-158. PMID 3606542 DOI: 10.1007/Bf01907062 |
0.491 |
|
| 1987 |
Arnold JM, Antman EM, Przyklenk K, Braunwald E, Sandor T, Vivaldi MT, Schoen FJ, Kloner RA. Differential effects of reperfusion on incidence of ventricular arrhythmias and recovery of ventricular function at 4 days following coronary occlusion. American Heart Journal. 113: 1055-65. PMID 3577998 DOI: 10.1016/0002-8703(87)90912-4 |
0.477 |
|
| 1987 |
Kloner RA, Przyklenk K, Campbell CA. Coronary reperfusion following experimental myocardial infarction. Journal of Cardiac Surgery. 2: 291-295. PMID 2979979 DOI: 10.1111/J.1540-8191.1987.Tb00185.X |
0.52 |
|
| 1987 |
Przyklenk K, Kloner RA. Acute effects of hydralazine and enalapril on contractile function of postischemic "stunned" myocardium. American Journal of Cardiology. 60: 934-936. PMID 2821788 DOI: 10.1016/0002-9149(87)91059-9 |
0.359 |
|
| 1986 |
Przyklenk K, Vivaldi MT, Arnold JMO, Schoen FJ, Kloner RA. Capillary anastomoses between the left anterior descending and circumflex circulations in the canine heart: possible importance during coronary artery occlusion. Microvascular Research. 31: 54-65. PMID 3959915 DOI: 10.1016/0026-2862(86)90006-3 |
0.407 |
|
| 1986 |
Przyklenk K, Kloner RA. Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium". Circulation Research. 58: 148-156. PMID 3943152 DOI: 10.1161/01.Res.58.1.148 |
0.502 |
|
| 1986 |
Przyklenk K, Vivaldi MT, Schoen FJ, Arnold JMO, Kloner RA. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion Cardiovascular Research. 20: 403-414. PMID 3779738 DOI: 10.1093/Cvr/20.6.403 |
0.494 |
|
| 1986 |
Campbell CA, Przyklenk K, Kloner RA. Infarct size reduction: a review of the clinical trials The Journal of Clinical Pharmacology. 26: 317-329. PMID 2871053 DOI: 10.1002/J.1552-4604.1986.Tb03532.X |
0.426 |
|
| 1984 |
Przyklenk K, Groom AC. Can exercise promote revascularization in the transition zone of infarcted rat hearts Canadian Journal of Physiology and Pharmacology. 62: 630-633. PMID 6744106 DOI: 10.1139/Y84-102 |
0.37 |
|
| 1983 |
Przyklenk K, Groom AC. Microvascular evidence for a transition zone around a chronic myocardial infarct in the rat Canadian Journal of Physiology and Pharmacology. 61: 1516-1522. PMID 6671164 DOI: 10.1139/Y83-217 |
0.391 |
|
| Show low-probability matches. |